company background image

EkoCorpNGSE:EKOCORP Stock Report

Market Cap







18 Oct, 2021


Company Financials
EKOCORP fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health4/6

EKOCORP Overview

EkoCorp Plc provides healthcare services in Nigeria.

Price History & Performance

Summary of all time highs, changes and price drops for EkoCorp
Historical stock prices
Current Share Price₦5.79
52 Week High₦5.40
52 Week Low₦6.00
1 Month Change-1.86%
3 Month Change-1.86%
1 Year Change-3.50%
3 Year Change71.81%
5 Year Change63.56%
Change since IPO201.56%

Recent News & Updates

Shareholder Returns

EKOCORPNG HealthcareNG Market

Return vs Industry: EKOCORP underperformed the NG Healthcare industry which returned 29.5% over the past year.

Return vs Market: EKOCORP underperformed the NG Market which returned 40% over the past year.

Price Volatility

Is EKOCORP's price volatile compared to industry and market?
EKOCORP volatility
EKOCORP Beta-0.19
Industry Beta0.39
Market Beta1

Stable Share Price: EKOCORP is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 1% a week.

Volatility Over Time: EKOCORP's weekly volatility (1%) has been stable over the past year.

About the Company

1977296A. Ogunmokun

EkoCorp Plc provides healthcare services in Nigeria. It provides diagnosis, laboratory test, scanning, X-ray, and surgery services. The company was founded in 1977 and is based in Lagos, Nigeria.

EkoCorp Fundamentals Summary

How do EkoCorp's earnings and revenue compare to its market cap?
EKOCORP fundamental statistics
Market Cap₦2.89b
Earnings (TTM)-₦373.27m
Revenue (TTM)₦932.31m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EKOCORP income statement (TTM)
Cost of Revenue₦839.05m
Gross Profit₦93.25m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date


Earnings per share (EPS)-0.75
Gross Margin10.00%
Net Profit Margin-40.04%
Debt/Equity Ratio21.1%

How did EKOCORP perform over the long term?

See historical performance and comparison


Is EkoCorp undervalued compared to its fair value and its price relative to the market?


Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: EKOCORP (NGN5.79) is trading above our estimate of fair value (NGN3.74)

Significantly Below Fair Value: EKOCORP is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: EKOCORP is unprofitable, so we can't compare its PE Ratio to the African Healthcare industry average.

PE vs Market: EKOCORP is unprofitable, so we can't compare its PE Ratio to the NG market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EKOCORP's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: EKOCORP is good value based on its PB Ratio (1.2x) compared to the XF Healthcare industry average (2.7x).

Future Growth

How is EkoCorp forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EkoCorp has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has EkoCorp performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EKOCORP is currently unprofitable.

Growing Profit Margin: EKOCORP is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: EKOCORP is unprofitable, but has reduced losses over the past 5 years at a rate of 0.7% per year.

Accelerating Growth: Unable to compare EKOCORP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EKOCORP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4.5%).

Return on Equity

High ROE: EKOCORP has a negative Return on Equity (-15.94%), as it is currently unprofitable.

Financial Health

How is EkoCorp's financial position?

Financial Position Analysis

Short Term Liabilities: EKOCORP's short term assets (NGN370.1M) do not cover its short term liabilities (NGN1.5B).

Long Term Liabilities: EKOCORP's short term assets (NGN370.1M) do not cover its long term liabilities (NGN2.6B).

Debt to Equity History and Analysis

Debt Level: EKOCORP's debt to equity ratio (21.1%) is considered satisfactory.

Reducing Debt: EKOCORP's debt to equity ratio has reduced from 23.1% to 21.1% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable EKOCORP has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: EKOCORP is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 10.8% per year.


What is EkoCorp current dividend yield, its reliability and sustainability?

Dividend Yield vs Market

Notable Dividend: Unable to evaluate EKOCORP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EKOCORP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EKOCORP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EKOCORP's dividend payments have been increasing.

Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EKOCORP's dividend in 3 years as they are not forecast to pay a notable one for the NG market.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


A. Ogunmokun

no data


Dr. A. Adegbite Ogunmokun serves as Chief Medical Officer and Acting Chief Executive Officer at EkoCorp Plc. Dr. Ogunmokun also serves as Chief Consultant Obsterician/Gynaecologist and also Head of the Eko...


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

EkoCorp Plc's employee growth, exchange listings and data sources

Key Information

  • Name: EkoCorp Plc
  • Ticker: EKOCORP
  • Exchange: NGSE
  • Founded: 1977
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ₦2.887b
  • Shares outstanding: 498.60m
  • Website:

Number of Employees


  • EkoCorp Plc
  • 31, Mobolaji Bank-Anthony Way
  • Ikeja
  • Lagos
  • Nigeria


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 21:40
End of Day Share Price2021/10/18 00:00
Annual Earnings2020/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.